Patent intelligence · US
US 8287819
Device for synthesis of radiopharmaceutical products
Device for synthesis of radiopharmaceutical products
Patent details — US 8287819
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 16, 2012
- Expiration
- Oct 11, 2032
- Applicant
- Ion Beam Applications
- Claims
- 1
- CPC classes
- A61K, A61K51/04, A61K51/0491, A61K51/1282
Quick answer
US 8287819 (Device for synthesis of radiopharmaceutical products) is held by Ion Beam Applications. Status: granted. Granted Oct 16, 2012. Expires Oct 11, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Ion Beam Applications
- Grant date
- Expiration
- Claims
- 1
- CPC classes
- A61K, A61K51/04, A61K51/0491, A61K51/1282
More from Ion Beam Applications
Related pharmaceutical patents in our USPTO index.
-
US 12296053
Nanomaterials comprising triols
granted -
US 12268753
Nanomaterials comprising a biodegradable feature
granted -
US 12133884
Methods of substituting pathogenic amino acids using programmable base editor systems
granted -
US 12059477
Nanomaterials
granted -
US 12016908
Compositions and methods for treating hemoglobinopathies
granted -
US 11795443
Uses of adenosine base editors
granted -
US 11752202
Compositions and methods for treating hemoglobinopathies
granted -
US 11594345
Method for producing Ac-225 from Ra-226
granted
Frequently asked questions
What is US patent 8287819?
US 8287819 (Device for synthesis of radiopharmaceutical products) is held by Ion Beam Applications. Status: granted. Granted Oct 16, 2012. Expires Oct 11, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8287819?
Ion Beam Applications is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 14 pharmaceutical patents for this assignee.
When does US 8287819 expire?
Our index shows an expiration date of Oct 11, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.